Lanean...

Rethinking Phase II Clinical Trial Design in Heart Failure

The incidence and economic burden of heart failure continue to rise worldwide, despite implementation of a number of effective heart failure therapies. Although there have been a number phase I–II studies of potential novel heart failure therapies over the past decade, none of these new compounds ha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lavine, Kory J., Mann, Douglas L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4204480/
https://ncbi.nlm.nih.gov/pubmed/25343020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/cli.12.133
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!